This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Fosamax 70 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $7,170.74, and has an ultimate completion date of April 23, 2024.
Amerisourcebergen, through its Corporate Office division, is the prime contractor on this award. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
This contract award does not have a set-aside designation, indicating it was competed on a full and open basis. As a leading pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government contracts for critical medical products, supporting the DLA's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies.